According to ORIC Pharmaceuticals
's latest financial reports the company has HK$1.59 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | HK$1.98 B | 22.21% |
2023-12-31 | HK$1.62 B | 0.89% |
2022-12-31 | HK$1.61 B | -12.78% |
2021-12-31 | HK$1.84 B | -18.81% |
2020-12-31 | HK$2.27 B | 227.78% |
2019-12-31 | HK$0.69 B | 107.97% |
2018-12-31 | HK$0.33 B |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | HK$1.59 B | 0.00% | ๐บ๐ธ USA |